Pharmaceuticals

By passing this popular bipartisan legislation now, Congress can help make coverage and care more affordable for everyone.

By passing this popular bipartisan legislation now, Congress can help make coverage and care more affordable for everyone.

HHS' Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.

The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.

By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.

The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.

As the Trump administration pledges to bring down America’s high-and-rising drug prices, workers are living with the burden of costly medications.

By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.

The president will propose a sweeping effort to bring down U.S. drug prices in a plan to make good on a campaign promise.

By tying its clinical database to physicians’ EHR systems, the drug chain hopes to avoid patient sticker shock and prescription abandonment at the point of sale.

By tying its clinical database to physicians’ EHR systems, the drug chain hopes to avoid patient sticker shock and prescription abandonment at the point of sale.

Addiction recovery costs are skyrocketing for companies, but employee education on drug usage can help stem the tide.

Aetna will pass on the discounts it negotiates on prescription drugs to about 3 million of its members, in the latest move to address complaints about the cost of medicine.

Nominee Alex Azar was an executive at drugmaker Eli Lilly & Co. until January, a role that Democrats say raises concerns about whether he will take on high drug prices

CBG Benefits’ Jeanne Nicholson has successfully identified the needs of the biotech and pharma industries in New England by bringing them together under her HR BioTech Connect organization.

CBG Benefits’ Jeanne Nicholson has successfully identified the needs of the biotech and pharma industries in New England by bringing them together under her HR BioTech Connect organization.